DK1372611T3 - Farmaceutisk sammensætning omfattende staurosporin med ringe vandoplöselighed, et overfladeaktivt stof og en vandoplöselig polymer - Google Patents
Farmaceutisk sammensætning omfattende staurosporin med ringe vandoplöselighed, et overfladeaktivt stof og en vandoplöselig polymerInfo
- Publication number
- DK1372611T3 DK1372611T3 DK02732526T DK02732526T DK1372611T3 DK 1372611 T3 DK1372611 T3 DK 1372611T3 DK 02732526 T DK02732526 T DK 02732526T DK 02732526 T DK02732526 T DK 02732526T DK 1372611 T3 DK1372611 T3 DK 1372611T3
- Authority
- DK
- Denmark
- Prior art keywords
- surfactant
- water
- soluble
- staurosporin
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10114869 | 2001-03-26 | ||
DE2001117049 DE10117049A1 (de) | 2001-04-05 | 2001-04-05 | Zusammensetzung |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1372611T3 true DK1372611T3 (da) | 2006-09-18 |
Family
ID=26008913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK02732526T DK1372611T3 (da) | 2001-03-26 | 2002-03-26 | Farmaceutisk sammensætning omfattende staurosporin med ringe vandoplöselighed, et overfladeaktivt stof og en vandoplöselig polymer |
Country Status (15)
Country | Link |
---|---|
US (5) | US20040077232A1 (da) |
EP (1) | EP1372611B1 (da) |
JP (1) | JP4330343B2 (da) |
CN (1) | CN100350911C (da) |
AT (1) | ATE326216T1 (da) |
AU (1) | AU2002304784A1 (da) |
BR (1) | BR0208306A (da) |
CA (1) | CA2439097C (da) |
CY (1) | CY1106159T1 (da) |
DE (1) | DE60211494T2 (da) |
DK (1) | DK1372611T3 (da) |
ES (1) | ES2261671T3 (da) |
HK (1) | HK1061515A1 (da) |
PT (1) | PT1372611E (da) |
WO (1) | WO2002076432A2 (da) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003208245A1 (en) * | 2002-03-15 | 2003-09-29 | Kuyus, Stiftung | Composition and utilization thereof for forming a protective film on nasal mucous membranes |
JO2897B1 (en) | 2004-11-05 | 2015-09-15 | نوفارتيس ايه جي | Organic compounds |
PL2054040T3 (pl) * | 2006-08-16 | 2011-09-30 | Novartis Ag | Sposób wytwarzania stałych dyspersji midostauryny |
JP5161528B2 (ja) * | 2007-10-02 | 2013-03-13 | 浜松ホトニクス株式会社 | パクリタキセル微粒子、パクリタキセル微粒子分散液、および、これらの製造方法 |
US20090087460A1 (en) * | 2007-10-02 | 2009-04-02 | Hamamatsu Photonics K.K. | Solid composition, microparticles, microparticle dispersion liquid, and manufacturing methods for these |
JP5149585B2 (ja) * | 2007-10-02 | 2013-02-20 | 浜松ホトニクス株式会社 | 微粒子分散液製造方法 |
WO2009100176A2 (en) * | 2008-02-07 | 2009-08-13 | Abbott Laboratories | Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
WO2011000811A2 (en) * | 2009-06-30 | 2011-01-06 | Novartis Ag | Organic compounds |
JP6003653B2 (ja) * | 2011-08-17 | 2016-10-05 | 東レ株式会社 | 医療デバイスおよびその製造方法 |
US10478498B2 (en) | 2014-06-20 | 2019-11-19 | Reform Biologics, Llc | Excipient compounds for biopolymer formulations |
IL280052B2 (en) * | 2014-12-02 | 2023-09-01 | Minerva Neurosciences Inc | Preparations containing 2-((1-(2(4-fluorophenyl)-2-oxoethyl)piperidine-4-yl)methyl)isoindolin-1-one for the treatment of schizophrenia |
KR20170084736A (ko) * | 2016-01-12 | 2017-07-21 | 삼성디스플레이 주식회사 | 표시장치 |
US10279048B2 (en) | 2016-07-13 | 2019-05-07 | Reform Biologics, Llc | Stabilizing excipients for therapeutic protein formulations |
US11642199B2 (en) * | 2018-09-24 | 2023-05-09 | 3M Innovative Properties Company | Dental appliance with cosmetic therapeutic aqueous solution |
CN113797163B (zh) * | 2020-06-17 | 2023-07-14 | 成都瑞沐生物医药科技有限公司 | 一种滴眼给药防治干性黄斑病变和视网膜光损伤的眼用制剂 |
WO2024131725A1 (en) * | 2022-12-19 | 2024-06-27 | Shenzhen Pharmacin Co., Ltd. | Topical pharmaceutical compositions and uses thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3754082A (en) * | 1970-06-11 | 1973-08-21 | Richardson Merrell Inc | Process and composition for botfly larvae eliminination |
CA1141663A (en) * | 1979-09-06 | 1983-02-22 | Yukihisa Ishii | Ophthalmic solution for intraocular pressure adjustment |
JPS61194034A (ja) * | 1985-02-25 | 1986-08-28 | Teijin Ltd | 経鼻投与用粉末状組成物 |
JPS632932A (ja) * | 1986-06-23 | 1988-01-07 | Teijin Ltd | 経鼻投与用粉末状組成物 |
US5093330A (en) * | 1987-06-15 | 1992-03-03 | Ciba-Geigy Corporation | Staurosporine derivatives substituted at methylamino nitrogen |
US5213738A (en) * | 1990-05-15 | 1993-05-25 | L. Perrigo Company | Method for making a capsule-shaped tablet |
IT1245761B (it) * | 1991-01-30 | 1994-10-14 | Alfa Wassermann Spa | Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale. |
GB9325395D0 (en) * | 1993-12-11 | 1994-02-16 | Ciba Geigy Ag | Compositions |
AU1911095A (en) * | 1994-02-18 | 1995-09-04 | Cephalon, Inc. | Aqueous indolocarbazole solutions |
EP0733358A3 (de) * | 1995-03-21 | 1998-05-20 | Novartis AG | Intravenös applizierbare Nanosuspensionen |
CA2291735A1 (en) * | 1997-05-27 | 1998-12-03 | Takahiro Ogawa | Israpafant-containing water-base preparations |
TW546151B (en) * | 1997-07-23 | 2003-08-11 | Senju Pharma Co | Aqueous liquid pharmaceutical composition containing as main component benzopyran derivative |
DE19813661A1 (de) * | 1997-08-01 | 1999-02-04 | Solvay Pharm Gmbh | Gegen Racemisierung stabilisierte pharmazeutische Zubereitungen von Cilansetron |
GB9903547D0 (en) * | 1999-02-16 | 1999-04-07 | Novartis Ag | Organic compounds |
US6190869B1 (en) * | 1999-10-26 | 2001-02-20 | Isis Pharmaceuticals, Inc. | Antisense inhibition of protein kinase C-theta expression |
-
2002
- 2002-03-26 DE DE60211494T patent/DE60211494T2/de not_active Expired - Lifetime
- 2002-03-26 EP EP02732526A patent/EP1372611B1/en not_active Expired - Lifetime
- 2002-03-26 PT PT02732526T patent/PT1372611E/pt unknown
- 2002-03-26 AU AU2002304784A patent/AU2002304784A1/en not_active Abandoned
- 2002-03-26 US US10/469,757 patent/US20040077232A1/en not_active Abandoned
- 2002-03-26 AT AT02732526T patent/ATE326216T1/de active
- 2002-03-26 WO PCT/EP2002/003387 patent/WO2002076432A2/en active IP Right Grant
- 2002-03-26 CN CNB028073460A patent/CN100350911C/zh not_active Expired - Lifetime
- 2002-03-26 DK DK02732526T patent/DK1372611T3/da active
- 2002-03-26 BR BR0208306-0A patent/BR0208306A/pt active Search and Examination
- 2002-03-26 ES ES02732526T patent/ES2261671T3/es not_active Expired - Lifetime
- 2002-03-26 CA CA2439097A patent/CA2439097C/en not_active Expired - Fee Related
- 2002-03-26 JP JP2002574948A patent/JP4330343B2/ja not_active Expired - Lifetime
-
2004
- 2004-06-16 HK HK04104399A patent/HK1061515A1/xx not_active IP Right Cessation
-
2006
- 2006-08-03 CY CY20061101092T patent/CY1106159T1/el unknown
-
2008
- 2008-06-26 US US12/147,129 patent/US20080287417A1/en not_active Abandoned
-
2013
- 2013-09-12 US US14/025,219 patent/US20140018346A1/en not_active Abandoned
-
2014
- 2014-06-19 US US14/309,209 patent/US20140303145A1/en not_active Abandoned
-
2016
- 2016-06-20 US US15/186,736 patent/US20160287707A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PT1372611E (pt) | 2006-08-31 |
AU2002304784A1 (en) | 2002-10-08 |
JP2004534739A (ja) | 2004-11-18 |
EP1372611A2 (en) | 2004-01-02 |
WO2002076432A2 (en) | 2002-10-03 |
CA2439097C (en) | 2010-10-12 |
CY1106159T1 (el) | 2011-06-08 |
ATE326216T1 (de) | 2006-06-15 |
DE60211494T2 (de) | 2006-10-12 |
US20140018346A1 (en) | 2014-01-16 |
US20080287417A1 (en) | 2008-11-20 |
US20040077232A1 (en) | 2004-04-22 |
DE60211494D1 (de) | 2006-06-22 |
CN1499959A (zh) | 2004-05-26 |
EP1372611B1 (en) | 2006-05-17 |
US20160287707A1 (en) | 2016-10-06 |
ES2261671T3 (es) | 2006-11-16 |
CA2439097A1 (en) | 2002-10-03 |
JP4330343B2 (ja) | 2009-09-16 |
WO2002076432A3 (en) | 2002-12-12 |
US20140303145A1 (en) | 2014-10-09 |
CN100350911C (zh) | 2007-11-28 |
HK1061515A1 (en) | 2004-09-24 |
BR0208306A (pt) | 2004-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1106159T1 (el) | Φαρμακευτικη συνθεση που πepιλαμβανει πενιχρα υδατοδιαλυτη σταυροσπορινη, επιφανειοδραστικη ουσια και υδατοδιαλυτο πολυμepες | |
NO20061840L (no) | Legemiddelbelegg som tilveiebringer hoy legemiddeltilsetning og fremgangsmater for a tilveiebringe samme | |
EE05506B1 (et) | Ravimi manustamise vahend eriti progestiinide jastrogeenide manustamiseks | |
ATE292453T1 (de) | Antivirale arznei | |
DE69735002D1 (de) | Osmotisches Verabreichungssystem für lösliche Dosen | |
WO1998040069A3 (en) | Stabilization of acid sensitive benzimidazoles with amino acid/cyclodextrin combinations | |
ATE274344T1 (de) | Pharmazeutische zubereitung mit verzögerter wirkstofffreisetzung von phenytoin natrium | |
HUP0500846A2 (en) | Pharmaceutical formulation with an insoluble active agent for pulmonary administration | |
ATE284861T1 (de) | N-aralkylaminotetraline als neuropeptid-y-y5- rezeptorliganden | |
ATE541562T1 (de) | Ibuprofen-suspension | |
PT1556371E (pt) | Derivados de benzimidazole e sua utilizacao como pro-farmacos de inibadores da bomba de protoes. | |
BR0014378A (pt) | Derivados de ácido indolil-3-glioxìlico tendo propriedades terapeuticamente valiosas | |
BR0210489A (pt) | Formulação farmacêutica oral, processo para preparar a mesma, uso da mesa, e método para preparar um distúrbio cardiovascular em um paciente | |
AU2003293593A8 (en) | Pharmaceutical preparations, use of said preparations and method for increasing the bioavailability of medicaments for peroral administration | |
DK1957037T3 (da) | Farmaceutisk præparat til nasal anvendelse af fentanyl | |
NO20023551D0 (no) | Ibuprofen-inneholdende aktivt middel-preparat | |
DE60102590D1 (de) | Darreichungsformen zur behandlung von oralen mykosen | |
EE05415B1 (et) | Ravimi manustamise vahend, eriti androgeenide manustamiseks | |
DE50005082D1 (de) | Verfahren zu Herstellung von PULVERFÖRMIGEn SOLUBILISATIONSHILFSSTOFFEn FÜR FESTE PHARMAZEUTISCHE DARREICHUNGSFORMEN | |
NZ520927A (en) | Orally administered controlled delivery system for once daily administration of ciprofloxacin | |
DK1558219T3 (da) | Farmaceutisk formulering af olanzapin | |
DK1152763T3 (da) | Anvendelse af desozypeganin til behandling af stofafhængighed | |
ZA200304846B (en) | Use of chloroquine, hydroxychloroquine and 4 aminoquinolinic derivatives to obtain a drug for the anti retroviral therapy, active towards HIV sensitive strains. | |
NO20025028L (no) | 9-oksa-epotilonderivater, fremgangsmÕte for fremstilling derav samt deres anvendelse i farmasöytiske preparater | |
ATE340564T1 (de) | Arzneimittel mit verzögerter wirkstoffabgabe |